Business
Helix BioPharma Corp. Opens the Market
Helix BioPharma Corp. Opens the Market Helix BioPharma Corp. Opens the Market Ca...
About this update from Helix Biopharma Corp.
[{"type":"text","content":"\n\n\n\nHelix BioPharma Corp. Opens the Market\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nHelix BioPharma Corp. Opens the Market\nCanada NewsWire\nTORONTO, May 26, 2016\n\n\n\n\n\n\nTORONTO, May 26, 2016 /CNW/ - Dr. Sven Rohmann, CEO and President, Helix BioPharma Corp. (HBP), joined Richard Rohan, VP, Corporate Sales, TMX Equity Transfer & Trust Company, to open the market to celebrate 20 years listed on Toronto Stock Exchange. Helix BioPharma Corp. is a biopharmaceutical company specializing in the development and commercialization of medicines in the areas of cancer prevention and treatment. Helix BioPharma Corp. commenced trading on Toronto Stock Exchange on June 3, 1996.\nSOURCE TMX Group Limited\n\n\n\nImage with caption: \"Dr. Sven Rohmann, CEO and President, Helix BioPharma Corp. (HBP), joined Richard Rohan, VP, Corporate Sales, TMX Equity Transfer & Trust Company, to open the market to celebrate 20 years listed on Toronto Stock Exchange. Helix BioPharma Corp. is a biopharmaceutical company specializing in the development and commercialization of medicines in the areas of cancer prevention and treatment. Helix BioPharma Corp. commenced trading on Toronto Stock Exchange on June 3, 1996. (CNW Group/TMX Group Limited)\". Image available at: http://photos.newswire.ca/images/download/20160526_C2748_PHOTO_EN_700484.jpg\n\n\n\n\n\n\n\n\n\nCopyright CNW Group 2016","length":3158,"tagName":"div"}]